Guidewire Software Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Guidewire Software Inc. Common Stock trades at $165.66 (market cap $13.59B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Guidewire Software Inc. Common Stock is far larger — about 7.5× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Guidewire Software Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guidewire Software Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| GWRE | VIR | |
|---|---|---|
Market Cap | $13.59B | $1.80B |
Volume | 838,274 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $254.23 | $11.78 |
52-Week Low | $102.69 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.55B | $1.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Guidewire Software Inc. develops InsuranceSuite Cloud, a software platform used by property and casualty insurers for policy administration, billing, and claims processing.
Read more on GWRE →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →